EstechPharma In Talks With German Company For MRI Contrast Medium Agents; Korean API Makers Struggle For Global Foothold
This article was originally published in PharmAsia News
Executive Summary
SEOUL - South Korea's active pharmaceutical ingredient company EstechPharma is currently in talks with a German-based multinational company, likely Bayer Schering Pharma, to sell its two generic MRI contrast medium products
You may also be interested in...
Korea’s Dong-A Wins WHO Prequalification For TB Generic Of Lilly’s Seromycin As Firm Moves Up Value Chain
WHO prequalification clears path for Korea’s Dong-A to move from an API supplier of cycloserine to an exporter of finished products.
Italy's Bracco Taps Korea To Boost Sales Of Medical Contrast Mediums; Takes On Bayer Schering And GE Healthcare
SEOUL - Italy's Bracco has opened a Korean unit as part of its efforts to increase share for its medical contrast mediums in a market already dominated by Bayer Schering Pharma and GE Healthcare
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).